Physician profile
Bilal Farhan
NPI 1609329101
$5,503.70
in general payments reported to CMS, 2019-2025
11 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.81 · 2020: $1,357 · 2021: $271 · 2022: $2,283 · 2023: $732 · 2024: $515 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,302.33 | 2019-2025 | Solyx Sis System, Moses, Axonics |
| Coloplast Corp | $1,301.60 | 2020-2024 | Altis, Titan, Speedicath |
| Medtronic, INC. | $1,256.15 | 2021-2024 | Interstim, Nuro |
| Axonics, INC. | $250.53 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $152.97 | 2023-2024 | Gemtesa |
| Bluewind Medical | $103.62 | 2024 | Revi |
| Healthtronics Stone Solutions, LLC | $56.59 | 2020 | |
| Ambu INC. | $29.65 | 2024 | |
| Procept Biorobotics Corporation | $19.07 | 2025 | |
| Medtronic USA, INC. | $18.03 | 2020 | |
| Endo Pharmaceuticals INC. | $13.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Farhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.